0

0

0

0

0

0

0

0

0

Coronavirus News Highlights: Maharashtra reports 3,783 COVID cases, 56 deaths

Mini

Coronavirus India News LIVE Updates: Daily new cases of coronavirus in India continued to remained below 30,000 with the country recording 27,176 fresh COVID-19 cases, while 284 new fatalities were recorded, according to the Union Health Ministry data updated on Wednesday. With the fresh cases, India's total tally of COVID-19 cases rose to 3,33,16,755, while the death toll has climbed to 4,43,497, according to the data updated at 8 am. The active cases declined to 3,51,087 comprising 1.05 percent of the total infections, while the national COVID-19 recovery rate was recorded at 97.62 percent, the ministry said. A reduction of 11,120 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. The number of people who have recuperated from the disease surged to 3,25,22,171, while the case fatality rate was recorded at 1.33 percent.

Coronavirus News Highlights: Maharashtra reports 3,783 COVID cases, 56 deaths
  • With that it's a wrap to the LIVE updates on the coronavirus pandemic for today. Do join us tomorrow for the top developments on the COVID-19 situation from India and around the world. Until then stay safe and good night.
     
  • Maharashtra reports 3,783 COVID cases, 56 deaths

    Maharashtra on Wednesday reported 3,783 new coronavirus cases and 56 fresh fatalities, taking the infection tally to 65,07,930 and the toll to 1,38,277, a health department official said. The number of daily cases and fatalities witnessed a marginal rise as compared to Tuesday, when the state had reported 3,530 COVID-19 cases and 52 fatalities. The official said 4,364 patients were discharged from hospitals in the last 24 hours, taking the count of recovered cases to 63,17,070 and leaving Maharashtra with 49,034 active cases.The state has 2,87,356 people in home quarantine and another 1,926 in institutional quarantine, he said.

  • Moderna Covid vaccine produces lasting immune response, study finds
    While the Moderna COVID-19 vaccine led to strong immune and antibody responses for at least six months after clinical trial participants were fully vaccinated, it is likely that the immune response…
    Coronavirus News Highlights: Maharashtra reports 3,783 COVID cases, 56 deaths
  • Over 80% of eligible populace received first dose of COVID vaccine: Kerala CM

    Over 80 per cent of the population which is eligible for vaccination in the state has been administered the first dose of COVID-19 vaccine, Kerala Chief Minister Pinarayi Vijayan said on Wednesday.The CM, at a press conference, said that over 32 per cent of the population eligible for vaccination have received both jabs of the vaccine. He said the state government's endeavour was to ensure that all those above 18 years of age are administered the first dose of vaccine by the end of September and both doses in 2-3 months time.Speaking to the media about the COVID-19 situation in the state, the CM said that there was an increase in the number of people who are reaching hospitals late after getting infected by COVID-19 and that this trend was not heartening or encouraging.

  • Tamil Nadu reports 1,658 new COVID cases, 29 deaths 

    COVID19 | Tamil Nadu reports 1,658 new cases, 29 deaths and 1,542 recoveries; Active cases 16,636

  • Vaccinations has crossed 76 crore mark: Govt 

    India administered more than 57 lakh vaccine doses till 7pm today. With this, the total number of vaccinations has crossed the 76 crore mark: Government of India

  • Bengaluru civic agency to identify students with COVID symptoms

    With the reopening of schools and colleges, the city civic agency has decided to identify schoolgoing children showing COVID19 like symptoms for more than two days to control the spread of the disease. The Chief Commissioner of Bruhat Bengaluru Mahanagara Palike, Gaurav Gupta, on Wednesday said he has asked school managements in Bengaluru to check for Covid19 in children with symptoms persisting for more than two days to control the spread of the virus in the city.

  • Russia's COVID-19 single dose vaccine Sputnik Light gets SEC node for Phase III trials

    The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation has  recommended the conduct of Phase III clinical trials of Russia's single dose COVID19 vaccine Sputnik Light. According to the recommendations of the SEC meeting held last month, Dr Reddy's, which has tied up with Russian Direct Investment Fund to market the jab in India, presented updated safety, immunogenicity and efficacy data of Phase III clinical trial of Sputnik Light vaccine conducted in Russia, along with the proposal to conduct the  clinical trial in India.

  • Andhra reports 1,445 new COVID cases, 11 deaths

    Andhra Pradesh reported 1,445 fresh cases of coronavirus, 1,243 recoveries and 11 deaths in 24 hours ending 9 am on Wednesday. The number of active cases now stood at 14,603, a health department bulletin said. The state COVID-19 chart showed a gross of 20,33,419 positives, 20,04,786 recoveries and 14,030 deaths. East Godavari once again reported the highest number of 274 fresh cases in 24 hours, followed by Chittoor 201, Krishna 164, Guntur 141, Prakasam 136, West Godavari and Kadapa 131 each and SPS Nellore 130.

  • Joe Biden says nearly 3 million get health coverage during COVID-19 sign-up

    President Joe Biden announced Wednesday that 2.8 million consumers took advantage of a special six-month period to sign up for private health insurance coverage made more affordable by his COVID-19 relief law. He called the number encouraging and urged Congress to help lower health care costs. Thats 2.8 million families who will have more security, more breathing room, and more money in their pocket if an illness or accident hits home, Biden said. Altogether, 12.2 million Americans are actively enrolled in coverage under the Affordable Care Act an all-time high.

  • COVID-19: Restaurants, bars urge HC to direct Delhi govt, police not to interfere with sale of herbal hookahs

    Several restaurants and bars Wednesday urged the Delhi High Court to direct the AAP government and police not to interfere with the sale of herbal flavoured hookahs or take coercive steps against them. The plea was opposed by the Delhi government which said use of hookah, be it with or without tobacco, in all public places including hotels, restaurants, eatery houses, bars, pubs and discotheques, in the national capital is strictly prohibited as use or sharing of hookah may further increase spread of COVID19.

  • Hong Kong 2022 Gay Games postponed amid COVID-19 travel restrictions

    The 2022 Gay Games due to be held in Hong Kong will be postponed for a year because of the coronavirus, a delay to Asia's inaugural hosting of an event that could raise hope in a region where intolerance is common, organisers said on Wednesday. Hong Kong was to host the games in November next year but the global financial hub has some of the world's strictest coronavirus quarantine regulations as it aims to prevent any local cases of COVID-19 re-emerging.

  • Telangana   administers 2 crore COVID-19 vaccine doses

    Achieving a significant milestone in COVID19 inoculation, the Telangana  government administered a total of two crore vaccine doses in the state by Wednesday.  "We have given two crore (20 million) doses of COVID vaccine in the state so far," state Director of Public Health G Srinivasa Rao said.

  • Sputnik V demonstrates 97.2% efficacy and high safety profile against COVID: RDIF

    The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of the Republic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campaign in the country. The Russian vaccine has demonstrated 97.2% efficacy against coronavirus in Belarus. The efficacy of Sputnik V was measured based on data from more than 860,000 people vaccinated between January and July 2021.

  • Glenmark concludes study on COVID drug Favipiravir

    Drug firm Glenmark Pharmaceuticals on Wednesday said it has successfully completed its post-marketing surveillance study on Favipiravir in India. The study commenced in July 2020 to evaluate the safety and efficacy of Favipiravir in mild to moderate COVID-19 patients, Glenmark said in a statement. Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diarrhoea, vomiting etc were found to be mild in nature. The time for fever resolution was 4 days, while the time for the clinical cure was 7 days, it added. 

  • World cross country championships postponed to 2023 due to COVID restrictions

    Next year's world cross country championships have been pushed back to 2023 due to COVID-19 travel restrictions in Australia, governing body World Athletics said on Wednesday. Australia has some of the tightest restrictions in the world aimed at preventing the spread of the novel coronavirus, including limiting the number of arrivals and imposing a mandatory 14-day hotel quarantine on those entering the country.

  • Moderna Covid vaccine produces lasting immune response, study finds

    Immunity generated by the Moderna COVID-19 vaccine lasts for at least six months, and there is no indicator that vaccinated people will need a booster shot, according to a study. The research, published in the journal Science, noted that this time point of six months is critical because that is when true immune memory has formed. While the Moderna COVID-19 vaccine led to strong immune and antibody responses for at least six months after clinical trial participants were fully vaccinated, it is likely that the immune response could last much longer, the researchers said. They also show that this strong immune memory lasted in all age groups tested, including in people over age 70, a demographic especially vulnerable to severe COVID-19.

  • Moderna Covid vaccine produces lasting immune response, study finds

     

    Immunity generated by the Moderna COVID-19 vaccine lasts for at least six months, and there is no indicator that vaccinated people will need a booster shot, according to a study. The research, published in the journal Science, noted that this time point of six months is critical because that is when true immune memory has formed. While the Moderna COVID-19 vaccine led to strong immune and antibody responses for at least six months after clinical trial participants were fully vaccinated, it is likely that the immune response could last much longer, the researchers said. They also show that this strong immune memory lasted in all age groups tested, including in people over age 70, a demographic especially vulnerable to severe COVID-19.

  • EU pledges 200 million more COVID vaccine doses to Africa  

     

    The European Union is committing 200 million more coronavirus vaccine doses to Africa to help curb the COVID-19 pandemic on a global scale. European Commission President Ursula von der Leyen said that the new donation to be fully delivered by the middle of next year comes on top of 250 million already pledged and underscores the EU resolve to boost the challenge low-income nations are facing. Von der Leyen called it an investment in solidarity and it is an investment also in global health. She said that on top of delivering 700 million doses to Europeans, the 27-nation bloc had also sent as many to a combined 130 nations.

  • The Delhi government issues list of activities permitted from intervening night of 15-16 Sept till intervening night of September 30-October 1.

  • Russian Direct Investment Fund announces real-world data of Ministry of Health, Belarus on Russian Sputnik V vaccine confirming its high efficacy during vaccination campaign in the country. It demonstrated 97.2 percent efficacy against COVID in Belarus: Russian Direct Investment Fund

    The efficacy of Sputnik V was measured based on data from more than 860,000 people vaccinated between January and July 2021: Russian Direct Investment Fund

  • Odisha reports more recoveries than fresh COVID-19 cases for five days

     

    Odisha reported more recoveries than new COVID-19 cases for the fifth consecutive day with 793 people recuperating from the disease and 457 fresh infections, a health department official said. The new cases pushed the tally to 10,17,718, while 10,03,603 people have recovered from the disease. The single-day recoveries in the last four days were above 680, while the fresh cases were in the range of 420 to 650, he said. With an improvement in the COVID situation, none of the 30 districts of Odisha is now in the red zone, the official said. The coastal state now has 5,948 active cases. Of the 457 fresh cases, 265 were reported from quarantine centres and 192 detected during contact tracing. Seventy-three children and adolescents are among the new patients, and the daily infection rate among people below 18 years of age currently stands at 15.97 percent, he said.

  • West Bengal extends COVID restrictions till Sep 30, night curbs to continue

     

    The West Bengal government extended the COVID-related restrictions till September 30 with the existing relaxations, as per official notification. The restrictions, first imposed on May 16 and extended at regular intervals, were set to expire on Wednesday. "Wearing of masks, maintenance of physical distancing, and health and hygiene protocols must be followed at all times," the notification said. The state government has allowed offices, both government and private, to function with half the manpower, as per the order. "All outdoor activities including movement of people and vehicles shall be strictly prohibited between 11 pm to 5 am except for health services, law and order, essential commodities including agriculture produce and other emergency services," the order said. 

  • Glenmark concludes study on COVID-19 drug Favipiravir

    Drug firm Glenmark Pharmaceuticals on Wednesday said it has successfully completed its post-marketing surveillance study on Favipiravir in India. The study commenced in July 2020 to evaluate the safety and efficacy of Favipiravir in mild to moderate COVID-19 patients, Glenmark said in a statement.

    Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diarrhoea, vomiting etc were found to be mild in nature. The time for fever resolution was 4 days, while the time for the clinical cure was 7 days, it added. (PTI)

  • Restaurants, bars urge HC to direct Delhi govt, police not to interfere with sale of herbal hookahs

    Several restaurants and bars Wednesday urged the Delhi High Court to direct the AAP government and police not to interfere with the sale of herbal flavoured hookahs or take coercive steps against them. The plea was opposed by the Delhi government which said use of hookah, be it with or without tobacco, in all public places including hotels, restaurants, eatery houses, bars, pubs and discotheques, in the national capital is strictly prohibited as use or sharing of hookah may further increase spread of COVID-19. Justice Rekha Palli listed the matter for further hearing on September 20 as the counsel for petitioner restaurants and bars said he would file an additional affidavit. (PTI)

  • The Drugs Controller General of India has granted permission to conduct the Phase III bridging trials of Sputnik Light on the Indian population. The Sputnik Light is a single-dose Covid-19 vaccine of the Russian vaccine Sputnik V.

  • Single-day recoveries surpass fresh COVID-19 cases in Arunachal Pradesh

    Single-day recoveries outnumbered fresh COVID-19 cases in Arunachal Pradesh as 69 more people recuperated from the disease in the last 24 hours, while 65 new infections were reported, a health department official said on Wednesday. The new cases pushed the tally in the northeastern state to 53,872.  The recovery rate among COVID-19 patients is currently at 98.52 percent, State Surveillance Officer Dr Lobsang Jampa said. The positivity ratio currently stands at 1.63 percent. The state currently has 528 active cases.

  • Madhya Pradesh: Over 1 crore people fully vaccinated against COVID-19, says official

    More than 1 crore people are now fully vaccinated against COVID-19 in Madhya Pradesh out of the eligible population of 5.40 crore, health officials said on Wednesday. Till Tuesday, 1,00,09,759 people in Madhya Pradesh received both doses of COVID-19 vaccine, said Priyanka Das, managing director of the National Health Mission (NHM) in MP. So far, a total of 5,21,53,251 people have been inoculated in the state and out of them, 4,21,43,492 have received the first dose, while the remaining have got both the jabs, she said. The state is also gearing up to launch a 'mega campaign 3.0' on September 17, the birthday of Prime Minister Narendra Modi, and has set a target to inoculating 32.90 lakh people on that day, another official said. The MP government has set a target of district-wise record vaccinations on that day, the official added.

  • India top source of social media misinformation on COVID-19: Study

     

    India produced the largest amount of social media misinformation on COVID-19 due to the country's higher internet penetration rate, increasing social media consumption and users' lack of internet literacy, according to a new study. The study, 'Prevalence and Source Analysis of COVID-19 Misinformation in 138 Countries', was published in Sage's International Federation of Library Associations and Institutions journal. The study analysed 9,657 pieces of misinformation that originated in 138 countries. They were fact-checked by 94 organisations to understand the prevalence and sources of misinformation in different countries. "Of all the countries, India (18.07 percent) produced the largest amount of social media misinformation, perhaps thanks to the country's higher internet penetration rate, increasing social media consumption and users' lack of internet literacy," the study said.

  • Pondicherry sees 124 new COVID-19 cases, 2 deaths

    Puducherry clocked 124 fresh coronavirus infections during the last 24 hours ending 10 a.m. on Wednesday, raising the overall tally to 1,25,063. Two more patients hailing from Puducherry succumbed to the viral infection, raising the toll to 1,825.Director of the Department of Health G Sriramulu said there were 900 active cases of whom 170 patients were undergoing treatment in hospitals while the remaining 730 patients were in home isolation. While 80 patients recovered and were discharged in the last twenty-four hours the overall recoveries were 1,22,338. The Department of Health has tested so far 17.16 lakh samples and has found 14.56 lakh out of them to be negative.  The test positivity rate was 2.32 percent while fatality and recovery rates were 1.46 percent and 97.82 percent respectively.

Daily new cases of coronavirus in India continued to remained below 30,000 with the country recording 27,176 fresh COVID-19 cases, while 284 new fatalities were recorded, according to the Union Health Ministry data updated on Wednesday. With the fresh cases, India's total tally of COVID-19 cases rose to 3,33,16,755, while the death toll has climbed to 4,43,497, according to the data updated at 8 am. The active cases declined to 3,51,087 comprising 1.05 percent of the total infections, while the national COVID-19 recovery rate was recorded at 97.62 percent, the ministry said. A reduction of 11,120 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. The number of people who have recuperated from the disease surged to 3,25,22,171, while the case fatality rate was recorded at 1.33 percent.